Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 5;8(8):CD012977.
doi: 10.1002/14651858.CD012977.pub2.

Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews

Simon S Craig  1   2   3   4 , Stuart R Dalziel  5   4   6 , Colin Ve Powell  7   8 , Andis Graudins  9   4   10 , Franz E Babl  2   4   11   12 , Carole Lunny  13
Affiliations

Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews

Simon S Craig et al. Cochrane Database Syst Rev. .

Abstract

Background: Asthma is an illness that commonly affects adults and children, and it serves as a common reason for children to attend emergency departments. An asthma exacerbation is characterised by acute or subacute worsening of shortness of breath, cough, wheezing, and chest tightness and may be triggered by viral respiratory infection, poor compliance with usual medication, a change in the weather, or exposure to allergens or irritants. Most children with asthma have mild or moderate exacerbations and respond well to first-line therapy (inhaled short-acting beta-agonists and systemic corticosteroids). However, the best treatment for the small proportion of seriously ill children who do not respond to first-line therapy is not well understood. Currently, a large number of treatment options are available and there is wide variation in management.

Objectives: Main objective - To summarise Cochrane Reviews with or without meta-analyses of randomised controlled trials on the efficacy and safety of second-line treatment for children with acute exacerbations of asthma (i.e. after first-line treatments, titrated oxygen delivery, and administration of intermittent inhaled short-acting beta2-agonists and oral corticosteroids have been tried and have failed) Secondary objectives - To identify gaps in the current evidence base that will inform recommendations for future research and subsequent Cochrane Reviews - To categorise information on reported outcome measures used in trials of escalation of treatment for acute exacerbations of asthma in children, and to make recommendations for development and reporting of standard outcomes in future trials and reviews - To identify relevant randomised controlled trials that have been published since the date of publication of each included review METHODS: We included Cochrane Reviews assessing interventions for children with acute exacerbations of asthma. We searched the Cochrane Database of Systematic Reviews. The search is current to 28 December 2019. We also identified trials that were potentially eligible for, but were not currently included in, published reviews. We assessed the quality of included reviews using the ROBIS criteria (tool used to assess risk of bias in systematic reviews). We presented an evidence synthesis of data from reviews alongside an evidence map of clinical trials. Primary outcomes were length of stay, hospital admission, intensive care unit admission, and adverse effects. We summarised all findings in the text and reported data for each outcome in 'Additional tables'.

Main results: We identified 17 potentially eligible Cochrane Reviews but extracted data from, and rated the quality of, 13 reviews that reported results for children alone. We excluded four reviews as one did not include any randomised controlled trials (RCTs), one did not provide subgroup data for children, and the last two had been updated and replaced by subsequent reviews. The 13 reviews included 67 trials; the number of trials in each review ranged from a single trial up to 27 trials. The vast majority of comparisons included between one and three trials, involving fewer than 100 participants. The total number of participants included in reviews ranged from 40 to 2630. All studies included children; 16 (24%) included children younger than two years of age. Most of the reviews reported search dates older than four years. We have summarised the published evidence as outlined in Cochrane Reviews. Key findings, in terms of our primary outcomes, are that (1) intravenous magnesium sulfate was the only intervention shown to reduce hospital length of stay (high-certainty evidence); (2) no evidence suggested that any intervention reduced the risk of intensive care admission (low- to very low-certainty evidence); (3) the risk of hospital admission was reduced by the addition of inhaled anticholinergic agents to inhaled beta2-agonists (moderate-certainty evidence), the use of intravenous magnesium sulfate (high-certainty evidence), and the use of inhaled heliox (low-certainty evidence); (4) the addition of inhaled magnesium sulfate to usual bronchodilator therapy appears to reduce serious adverse events during hospital admission (moderate-certainty evidence); (5) aminophylline increased vomiting compared to placebo (moderate-certainty evidence) and increased nausea and nausea/vomiting compared to intravenous beta2-agonists (low-certainty evidence); and (6) the addition of anticholinergic therapy to short-acting beta2-agonists appeared to reduce the risk of nausea (high-certainty evidence) and tremor (moderate-certainty evidence) but not vomiting (low-certainty evidence). We considered 4 of the 13 reviews to be at high risk of bias based on the ROBIS framework. In all cases, this was due to concerns regarding identification and selection of studies. The certainty of evidence varied widely (by review and also by outcome) and ranged from very low to high.

Authors' conclusions: This overview provides the most up-to-date evidence on interventions for escalation of therapy for acute exacerbations of asthma in children from Cochrane Reviews of randomised controlled trials. A vast majority of comparisons involved between one and three trials and fewer than 100 participants, making it difficult to assess the balance between benefits and potential harms. Due to the lack of comparative studies between various treatment options, we are unable to make firm practice recommendations. Intravenous magnesium sulfate appears to reduce both hospital length of stay and the risk of hospital admission. Hospital admission is also reduced with the addition of inhaled anticholinergic agents to inhaled beta2-agonists. However, further research is required to determine which patients are most likely to benefit from these therapies. Due to the relatively rare incidence of acute severe paediatric asthma, multi-centre research will be required to generate high-quality evidence. A number of existing Cochrane Reviews should be updated, and we recommend that a new review be conducted on the use of high-flow nasal oxygen therapy. Important priorities include development of an internationally agreed core outcome set for future trials in acute severe asthma exacerbations and determination of clinically important differences in these outcomes, which can then inform adequately powered future trials.

PubMed Disclaimer

Conflict of interest statement

SC: none known.

SRD: none known.

CP is a review author on an included review (Knightly 2017).

AG: none known.

FEB: none known.

CL: no conflicts of interest.

Figures

1
1
Flow diagram.
See this image and copyright information in PMC

Comment in

References

References to included reviews

Camargo 2003
    1. Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No: CD001115. [DOI: 10.1002/14651858.CD001115] - DOI - PMC - PubMed
Griffiths 2013
    1. Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No: CD000060. [DOI: 10.1002/14651858.CD000060.pub2] - DOI - PMC - PubMed
Griffiths 2016
    1. Griffiths B, Kew KM. Intravenous magnesium sulfate for treating children with acute asthma in the emergency department. Cochrane Database of Systematic Reviews 2016, Issue 4. Art. No: CD011050. [DOI: 10.1002/14651858.CD011050.pub2] - DOI - PMC - PubMed
Jat 2012
    1. Jat KR, Chawla D. Ketamine for management of acute exacerbations of asthma in children. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No: CD009293. [DOI: 10.1002/14651858.CD009293.pub2] - DOI - PMC - PubMed
Knightly 2017
    1. Knightly R, Milan SJ, Hughes R, Knopp-Sihota JA, Rowe BH, Normansell R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database of Systematic Reviews 2017, Issue 11. Art. No: CD003898. [DOI: 10.1002/14651858.CD003898.pub6] - DOI - PMC - PubMed
Korang 2016
    1. Korang SK, Feinberg J, Wetterslev J, Jakobsen JC. Non-invasive positive pressure ventilation for acute asthma in children. Cochrane Database of Systematic Reviews 2016, Issue 9. Art. No: CD012067. [DOI: 10.1002/14651858.CD012067.pub2] - DOI - PMC - PubMed
Mitra 2005
    1. Mitra A, Bassler D, Goodman K, Lasserson TJ, Ducharme FM. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No: CD001276. [DOI: 10.1002/14651858.CD001276.pub2] - DOI - PMC - PubMed
Normansell 2018
    1. Normansell R, Sayer B, Waterson S, Dennett EJ, Del Forno M, Dunleavy A. Antibiotics for exacerbations of asthma. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No: CD002741. [DOI: 10.1002/14651858.CD002741.pub2] - DOI - PMC - PubMed
Rodrigo 2006
    1. Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No: CD002884. [DOI: 10.1002/14651858.CD002884.pub2] - DOI - PMC - PubMed
Travers 2012a
    1. Travers AH, Milan SJ, Jones AP, Camargo CA Jr, Rowe BH. Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No: CD010179. [DOI: 10.1002/14651858.CD010179] - DOI - PMC - PubMed
Travers 2012b
    1. Travers AH, Jones AP, Camargo CA Jr, Milan SJ, Rowe BH. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No: CD010256. [DOI: 10.1002/14651858.CD010256] - DOI - PMC - PubMed
Vezina 2014
    1. Vezina K, Chauhan BF, Ducharme FM. Inhaled anticholinergics and short-acting beta2-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital. Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No: CD010283. [DOI: 10.1002/14651858.CD010283.pub2] - DOI - PMC - PubMed
Watts 2012
    1. Watts K, Chavasse RJPG. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No: CD006100. [DOI: 10.1002/14651858.CD006100.pub2] - DOI - PMC - PubMed

References to excluded reviews

Jones 2001
    1. Jones A, Rowe B, Peters J, Camargo C, Hammarquist C, Rowe B. Inhaled beta-agonists for asthma in mechanically ventilated patients. Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No: CD001493. [DOI: 10.1002/14651858.CD001493] - DOI - PubMed
Manser 2001
    1. Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients. Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No: CD001740. [DOI: 10.1002/14651858.CD001740] - DOI - PubMed
Rowe 2000
    1. Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CAJr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No: CD001490. [DOI: 10.1002/14651858.CD001490] - DOI - PMC - PubMed
Travers 2001
    1. Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA, Rowe BH. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No: CD002988. [DOI: 10.1002/14651858.CD002988] - DOI - PMC - PubMed

Additional references

Acworth 2009
    1. Acworth J, Babl F, Borland M, Ngo P, Krieser D, Schutz J, et al. Patterns of presentation to the Australian and New Zealand Paediatric Emergency Research Network. Emergency Medicine Australasia 2009;21(1):59-66. - PubMed
Adachi 2012
    1. Adachi M, Taniguchi H, Tohda Y, Sano Y, Ishine T, Smugar SS, et al. The efficacy and tolerability of intravenous montelukast in acute asthma exacerbations in Japanese patients. Journal of Asthma 2012;49(6):649-56. - PubMed
Alpern 2006
    1. Alpern ER, Stanley RM, Gorelick MH, Donaldson A, Knight S, Teach SJ, et al. Epidemiology of a pediatric emergency medicine research network: the PECARN core data project. Pediatric Emergency Care 2006;22(10):689-99. - PubMed
Asthma UK
    1. Asthma UK. Asthma facts and statistics. www.asthma.org.uk/about/media/facts-and-statistics/ (accessed 3 August 2017).
Aubuchon 2012
    1. Aubuchon K, Matsuda K, House L, Ferguson I, Schneider J, Lewis L. Increased serum albuterol concentrations may be associated with elevations of serum lactate in subjects with acute asthma exacerbations. Academic Emergency Medicine 2012;19:S312‐3.
Babl 2008
    1. Babl FE, Sheriff N, Borland M, Acworth J, Neutze J, Krieser D, et al. Paediatric acute asthma management in Australia and New Zealand: practice patterns in the context of clinical practice guidelines. Archives of Disease in Childhood 2008;93(4):307-12. - PubMed
Balshem 2011
    1. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6. - PubMed
Baudin 2017
    1. Baudin F, Buisson A, Vanel B, Massenavette B, Pouyau R, Javouhey E. Nasal high flow in management of children with status asthmaticus: a retrospective observational study. Annals of Intensive Care 2017;7(1):55. - PMC - PubMed
Becker 1984
    1. Becker AB, Nelson NA, Simons FE. The pulmonary index. Assessment of a clinical score for asthma. American Journal of Diseases of Children 1984;138(6):574-6. - PubMed
Biagini Myers 2015
    1. Biagini Myers JM, Simmons JM, Kercsmar CM, Martin LJ, Pilipenko VV, Austin SR, et al. Heterogeneity in asthma care in a statewide collaborative: the Ohio Pediatric Asthma Repository. Pediatrics 2015;135(2):271-9. - PubMed
Bigham 2010
    1. Bigham MT, Jacobs BR, Monaco MA, Brilli RJ, Wells D, Conway EM, et al. Helium/oxygen-driven albuterol nebulization in the management of children with status asthmaticus: a randomized, placebo-controlled trial. Pediatric Critical Care Medicine 2010;11(3):356-61. - PubMed
Brandão 2011
    1. Brandão DC, Britto MC, Pessoa MF, Sá Rafaela B, Alcoforado L, Matos LO, et al. Heliox and forward-leaning posture improve the efficacy of nebulized bronchodilator in acute asthma: a randomized trial. Respiratory Care 2011;56(7):947-52. - PubMed
BTS/SIGN 2019
    1. SIGN158 - British guideline on the management of asthma: a national clinical guideline. First published 2003. Revised edition published July 2019. www.brit-thoracic.org.uk/document-library/guidelines/asthma/btssign-guid... (accessed prior to 3 March 2020).
Castro‐Rodriguez 2015
    1. Castro-Rodriguez JA, Rodrigo JG, Rodríguez-Martínez CE. Principal findings of systematic reviews of acute asthma treatment in childhood. Journal of Asthma 2015;52(10):1038-45. - PubMed
Caudri 2009
    1. Caudri D, Wijga A, Schipper CM, Hoekstra M, Postma DS, Koppelman GH, et al. Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. Journal of Allergy and Clinical Immunology 2009;124(5):903-10.e1-7. - PubMed
Cave 2014
    1. Cave AJ, Atkinson LL. Asthma in preschool children: a review of the diagnostic challenges. Journal of the American Board of Family Medicine 2014;27(4):538-48. - PubMed
Chaudhury 2017
    1. Chaudhury A, Gaude GS, Hattiholi J. Effects of oral montelukast on airway function in acute asthma: a randomized trial. Lung India 2017;34(4):349-54. - PMC - PubMed
Chen 2008
    1. Chen Z-G, Li M, Chen H, Chen Y-F, Chen F-H, Ji J-Zhi. Efficacy of pulmicort suspension plus salbutamol and ipratropium bromide for management of acute asthma exacerbation in children: a comparative study. Journal of Southern Medical University 2008;28(3):470-2. - PubMed
Craig 2018
    1. Craig SS, Dalziel SR, Powell CVE, Graudins A, Babl FE, Lunny C. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews. Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No: CD012977. [DOI: 10.1002/14651858.CD012977] - DOI - PMC - PubMed
Craig 2020
    1. Craig S, Babl FE, Dalziel SR, Gray C, Powell C, Al Ansari K, et al. Acute severe paediatric asthma: study protocol for the development of a core outcome set, a Pediatric Emergency Reserarch Networks (PERN) study. Trials 2020;21(1):72. - PMC - PubMed
D'Avila 2008
    1. D'Avila RS, Piva JP, Marostica PJ, Amantea SL. Early administration of two intravenous bolus of aminophylline added to the standard treatment of children with acute asthma. Respiratory Medicine 2008;102(1):156-61. - PubMed
Ducharme 2008
    1. Ducharme FM, Chalut D, Plotnick L, Savdie C, Kudirka D, Zhang X, et al. The pediatric respiratory assessment measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. Journal of Pediatrics 2008;152(4):476-80, 480.e1. - PubMed
Ferguson 2006
    1. Ferguson C, Gidwani S. Best evidence topic reports. Delivery of bronchodilators in acute asthma in children. Emergency Medicine Journal 2006;23(6):471-2. - PMC - PubMed
GINA 2019
    1. Global Initiative for Asthma. 2019 GINA Report, Global Strategy for Asthma Management and Prevention 2019. https://ginasthma.org/gina-reports/ (accessed prior to 3 March 2020).
Giordano 2012
    1. Giordano K, Rodriguez E, Green N, Armani M, Richards J, Shaffer TH, et al. Pulmonary function tests in emergency department pediatric patients with acute wheezing/asthma exacerbation. Pulmonary Medicine 2012;2012:724139. [DOI: 10.1155/2012/724139] - DOI - PMC - PubMed
Goyal 2013
    1. Goyal S, Agrawal A. Ketamine in status asthmaticus: a review. Indian Journal of Critical Care Medicine 2013;17(3):154-61. - PMC - PubMed
GradePro 2015 [Computer program]
    1. GRADEpro GDT. Version accessed prior to 3 March 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.
Higgins 2019
    1. Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Chapter 8. Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
Higgins 2019a
    1. Higgins JPT, Li T, Deeks JJ. Chapter 6. Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
Hon 2017
    1. Hon KL, Leung AK. Management of status asthmaticus in children. Recent Patents on Inflammation and Allergy Drug Discovery 2017;11(1):12-21. - PubMed
House 2015
    1. House SL, Matsuda K, O'Brien G, Makhay M, Iwaki Y, Ferguson I, et al. Efficacy of a new intravenous β2-adrenergic agonist (bedoradrine, MN-221) for patients with an acute exacerbation of asthma. Respiratory Medicine 2015;109(10):1268-73. - PubMed
Jadad 1996
    1. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996;17(1):1-12. - PubMed
Kanchanateeraphong 2014
    1. Kanchanateeraphong S, Phongsamart G, Dangsuwan T, Vangveeravong M. Study of montelukast for the treatment of acute and post viral-induced wheezing. Journal of Allergy and Clinical Immunology 2014;133(2 Suppl 1):AB190.
Kelly 2004
    1. Kelly AM, Kerr D, Powell C. Is severity assessment after one hour of treatment better for predicting the need for admission in acute asthma? Respiratory Medicine 2004;98(8):777-81. - PubMed
Kenyon 2014
    1. Kenyon CC, Fieldston ES, Luan X, Keren R, Zorc JJ. Safety and effectiveness of continuous aerosolized albuterol in the non-intensive care setting. Pediatrics 2014;134(4):e976-82. - PubMed
Konstantinou 2013
    1. Konstantinou GN, Xepapadaki P, Manousakis E, Makrinioti H, Kouloufakou-Gratsia K, Saxoni-Papageorgiou P, et al. Assessment of airflow limitation, airway inflammation, and symptoms during virus-induced wheezing episodes in 4- to 6-year-old children. Journal of Allergy and Clinical Immunology 2013;131(1):87-93.e1-5. - PMC - PubMed
Lyttle 2015
    1. Lyttle MD, O'Sullivan R, Doull I, Hartshorn S, Morris I, Powell CV. Variation in treatment of acute childhood wheeze in emergency departments of the United Kingdom and Ireland: an international survey of clinician practice. Archives of Disease in Childhood 2015;100(2):121-5. - PubMed
Magazine 2016
    1. Magazine R, Shahul HA, Chogtu B, Kamath A. Comparison of oral montelukast with oral zileuton in acute asthma: a randomized, double-blind, placebo-controlled study. Lung India 2016;33(3):281-6. - PMC - PubMed
Magazine 2018
    1. Magazine R, Surendra VU, Chogtu B. Comparison of oral montelukast with oral ozagrel in acute asthma: a randomized, double-blind, placebo-controlled study. Lung India 2018;35(1):16-20. - PMC - PubMed
Mandhane 2017
    1. Mandhane PJ, Paredes Zambrano de Silbernagel P, Aung YN, Williamson J, Lee Bonita E, Spier S, et al. Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: a placebo-controlled randomized trial. PloS One 2017;12(8):e0182411. - PMC - PubMed
Martinez 1995
    1. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. New England Journal of Medicine 1995;332(3):133-8. - PubMed
Matsuse 2012
    1. Matsuse H, Fukahori S, Tsuchida T, Kawano T, Tomari S, Matsuo N, et al. Effects of a short course of pranlukast combined with systemic corticosteroid on acute asthma exacerbation induced by upper respiratory tract infection. Journal of Asthma 2012;49(6):637-41. - PubMed
Memon 2016
    1. Memon BN, Parkash AT, Ahmed KKM, Gowa Murtaza A, Bai C. Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma. Journal of Pakiston Medical Association 2016;66(3):243-6. - PubMed
Morimoto 2018
    1. Morimoto K, Shimizu N, Saito O, Kodani T, Iki Y, Nagai Y, et al. The impact of heliox on obstructive airway diseases with mechanical ventilation. A pilot study. Pediatric Critical Care Medicine 2018;19(6 Suppl 1):46.
Morris 2015
    1. Morris I, Lyttle MD, O'Sullivan R, Sargant N, Doull IJ, Powell CV. Which intravenous bronchodilators are being administered to children presenting with acute severe wheeze in the UK and Ireland? Thorax 2015;70(1):88-91. - PubMed
Motamed 2017
    1. Motamed H, Verki MM, Pooladzade M, Majidi A. Efficacy evaluation of nebulized magnesium, as an additional complementary treatment, in clinical and peak flow metric improvements of acute asthma attack: a randomized double-blinded clinical trial. Jundishapur Journal of Natural Pharmaceutical Products 2017;12:4.
Mustafa 2017
    1. Mustafa J, Iqbal SMJ, Azhar IA, Sultan MA. Nebulized magnesium sulphate as an adjunct therapy in the management of children presenting with acute exacerbation of asthma. Pakistan Journal of Medical and Health Sciences 2018;12(2):554‐5.
Naao 2007
    1. Naao M, Katsunuma T, Kim KC, Fujisawa T. Efficacy and safety of intravenous aminophylline in children with acute exacerbation of asthma: a multicenter randomized trial. Journal of Allergy and Clinical Immunology 2007;119(1 Suppl 2):8.
Naspitz 1987
    1. Naspitz CK, Sole D, Wandalsen N. Treatment of acute attacks of bronchial asthma. A comparative study of epinephrine (subcutaneous) and fenoterol (inhalation). Annals of Allergy 1987;59(1):21-4. - PubMed
Nath 2015
    1. Nath JB, Hsia RY. Children's emergency department use for asthma, 2001-2010. Academic Pediatrics 2015;15(2):225-30. - PMC - PubMed
National Asthma Council Australia 2019
    1. National Asthma Council Australia. Australian Asthma Handbook, Version 2.0. National Asthma Council Australia, Melbourne, 2019. https://www.asthmahandbook.org.au/about (accessed prior to 3 March 2020).
Navanandan 2017
    1. Navanandan Ni, Federico M, Mistry RD. Positive expiratory pressure for the treatment of acute asthma exacerbations: a randomized controlled trial. Journal of Pediatrics 2017;185:149-54.e2. - PubMed
Neame 2015
    1. Neame M, Aragon O, Fernandes RM, Sinha I. Salbutamol or aminophylline for acute severe asthma: how to choose which one, when and why? Archives of Disease in Childhood. Education and Practice Edition 2015;100(4):215-22. - PubMed
NHLBI 2007
    1. National Heart, Lung, and Blood Institute (NHLBI). National Asthma Education and Prevention Program Expert Panel Report 3: guidelines for the diagnosis and management of asthma 2007. www.nhlbi.nih.gov/health-pro/guidelines/current/asthma-guidelines/full-r... (accessed 3 August 2017).
O'Connor 2014
    1. O'Connor MG, Saville BR, Hartert TV, Arnold DH. Treatment variability of asthma exacerbations in a pediatric emergency department using a severity-based management protocol. Clinical Pediatrics 2014;53(13):1288-90. - PMC - PubMed
Ortiz 2012
    1. Ortiz JA, Fonseca JS, Salas-Segura DA. Use of heliox in moderate and severe asthma attacks in the emergency service Rafael Angel Calderon Guardia Hospital. A prospective study. Revista del Instituto Nacional de Enfermedades Respiratorias 2012;71(1):21-8.
Papadopoulos 2012
    1. Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, et al. International consensus on (ICON) pediatric asthma. Allergy 2012;67(8):976-97. - PMC - PubMed
Parkin 1996
    1. Parkin PC, Macarthur C, Saunders NR, Diamond SA, Winders PM. Development of a clinical asthma score for use in hospitalized children between 1 and 5 years of age. Journal of Clinical Epidemiology 1996;49(8):821-5. - PubMed
Pincheira 2020
    1. Pincheira MA, Bacharier LB, Castro-Rodriguez JA. Efficacy of macrolides on acute asthma or wheezing exacerbations in children with recurrent wheezing: a systematic review and meta-analysis. Pediatric Drugs 2020;22:217-28. - PubMed
Pollack 2018
    1. Pollock M, Fernandes RM, Becker LA, Pieper D, Hartling L. Chapter V. Overviews of reviews. Draft version (8 October 2018) for inclusion. in: Higgins JPT, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch V (editors). Cochrane Handbook for Systematic Reviews of Interventions. London: Cochrane. Available from www.training.cochrane.org/handbook.
Powell 2003
    1. Powell CV, Kelly AM, Kerr D. Lack of agreement in classification of the severity of acute asthma between emergency physician assessment and classification using the National Asthma Council Australia guidelines (1998). Emergency Medicine 2003;15(1):49-53. - PubMed
Powell 2012
    1. Powell C, Dwan K, Milan SJ, Beasley R, Hughes R, Knopp-Sihota JA, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No: CD003898. [DOI: 10.1002/14651858.CD003898.pub5] - DOI - PubMed
Rees 1967
    1. Rees HA, Millar JS, Donald KW. Adrenaline in bronchial asthma. Lancet 1967;2(7527):1164-7. - PubMed
Rehder 2017
    1. Rehder KJ. Adjunct therapies for refractory status asthmaticus in children. Respiratory Care 2017;62(6):849-65. - PubMed
Rose 2011
    1. Rose J, Cancelliere S, Matye P, O'Riordan M. Comparing a breath-actuated vs a conventional continuous-output nebulizer in treating acute asthma in a pediatric emergency department: an ongoing randomized controlled trial. Academic Emergency Medicine 2011;18(5):S83-4.
Sabato 2011
    1. Sabato K, Ward P, Hawk W, Gildengorin V, Asselin JM. Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department. Respiratory Care 2011;56(6):761-70. - PubMed
Schneider 2012
    1. Schneider J, Matsuda K, House SL, Ferguson I, Aubuchon K, Lewis L. Dyspnea scores may be a better predictor of hospital admissions than FEV1 for patients with acute asthma exacerbations. Academic Emergency Medicine 2012;19(s1):S312.
Schüneman 2019
    1. Schünemann HJ, Vist GE, Higgins JPT, Santesso N, Deeks JJ, Glasziou P, et al. Chapter 15, Interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
Sengul Gokalp 2013
    1. Sengul Gokalp A, Bicer S, Siraneci R. Efficiacy of nebulized ipratropium bromide in the treatment of acute asthma in children: randomised, double blind, placebo-controlled trial. Nobel Medicus 2013;9(1):67-75.
Shim 1984
    1. Shim C. Adrenergic agonists and bronchodilator aerosol therapy in asthma. Clinics in Chest Medicine 1984;5(4):659-68. - PubMed
Singhi 2014
    1. Singhi S, Grover S, Bansal A, Chopra K. Randomised comparison of intravenous magnesium sulphate, terbutaline and aminophylline for children with acute severe asthma. Acta Paediatrica 2014;103(12):1301-6. - PubMed
Supriyatno 2012
    1. Supriyatno B, Harumdini M, Indawati W. The efficacy of adding ipratropium bromide to salbutamol nebulization for mild acute asthma attack in children. Paediatric Respiratory Reviews 2012;13:S78.
Tiwari 2016
    1. Tiwari A, Guglani V, Jat KR. Ketamine versus aminophylline for acute asthma in children: a randomized, controlled trial. Annals of Thoracic Medicine 2016;11(4):283-8. - PMC - PubMed
Wang 2018
    1. Wang X, Zhou J, Zhao X, Yi X. Montelukast treatment of acute asthma exacerbations in children aged 2 to 5 years: a randomized, double-blind, placebo-controlled trial. Pediatric Emergency Care 2018;34(3):160-4. - PubMed
Weiss 2011
    1. Weiss AJ, Wier LM, Stocks C, Blanchard J. Overview of emergency department visits in the United States, 2011. HCUP Statistical Brief #174. June 2014. Rockville, MD: Agency for Healthcare Research and Quality. www.hcup-us.ahrq.gov/reports/statbriefs/sb174-Emergency-Department-Visit... (accessed 2 November 2017). - PubMed
Whiting 2016
    1. Whiting P, Savovic J, Higgins JP, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. Journal of Clinical Epidemiology 2016;69:225-34. - PMC - PubMed
Wilkinson 2018
    1. Wilkinson M, King B, Iyer S, Higginbotham E, Wallace A, Hovinga C, et al. Comparison of a rapid albuterol pathway with a standard pathway for the treatment of children with a moderate to severe asthma exacerbation in the emergency department. Journal of Asthma 2018;55(3):244-51. - PubMed
Wyatt 2015
    1. Wyatt EL, Borland ML, Doyle SK, Geelhoed GC. Metered-dose inhaler ipratropium bromide in moderate acute asthma in children: a single-blinded randomised controlled trial. Journal of Paediatrics and Child Health 2015;51(2):192-8. - PubMed
Zubairi 2013
    1. Zubairi AB, Salahuddin N, Khawaja A, Awan S, Shah AA, Haque AS, et al. A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation. BMC Pulmonary Medicine 2013;13:20. - PMC - PubMed

Publication types

MeSH terms